Official websites use .mil
Secure .mil websites use HTTPS
As a component of the U.S. Department of Defense’s Chemical and Biological Defense Program, the JPEO-CBRND protects the entire Joint Force – Army, Navy, Air Force, Marines, Coast Guard, and First Responders – through the advanced development of CBRN defense capabilities that enable our Warfighters to fight and win in a CBRN-contested environment.
The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND)'s core focus areas contribute to building a more lethal force, a priority in the National Defense Strategy, and streamline JPEO-CBRND efforts to meet the Joint Service’s needs in combating chemical, biological, radiological and nuclear (CBRN) threats.
Four Joint Project Managers (JPM) provide oversight for the portfolios, including JPM CBRN Protection, JPM CBRN Medical, JPM CBRN Sensors and JPM CBRN Special Operations Forces. Two Joint Project Leads (JPL) focus on CBRN defense enabling biotechnologies and CBRN integration. The JPLs also provide portfolio-wide enabling support across the JPEO-CBRND.
Provide integrated layered chemical, biological, radiological, and nuclear defense capabilities to the Joint Force across Combined Joint All-Domain Operations
A resilient Joint Force enabled to fight and win unencumbered by a chemical, biological, radiological, or nuclear environment; championed by innovative, agile, results-oriented acquisition professionals
JPM CBRN Protection develops, fields and sustains CBRN protection and mitigation capabilities for the warfighter and the Nation. They develop next-generation physical protection capabilities, like masks and suits, that reduce physiological burden and enhance protection against emerging threats. JPM CBRN Protection also develops contamination mitigation technologies, including decontamination systems, to significantly decrease the time and materials required to decontaminate personnel and equipment.
JPM CBRN Medical provides the advanced development and acquisition of medical solutions, such as nerve agent antidotes and diagnostic systems, to combat CBRN and emerging threats. They deliver safe, effective, and affordable medical solutions to counter threats and enable the Joint Force to fight and win in any denied environment. JPM CBRN Medical products span the continuum of medical care, providing an integrated layered medical defense, to include prevention, diagnosis, and treatment.
JPM CBRN Sensors develops, fields and sustains CBRN sensors, reconnaissance systems, and mobile laboratory capabilities. They provide integrated early warning by bringing together the products in their portfolio along with robotics and autonomous systems, decision support tools, machine learning and artificial intelligence to provide situational awareness and understanding of CBRN threats.
JPM CBRN SOF rapidly acquires and equips Special Operations and Special Purpose Forces with critical CBRN defense equipment necessary for mission success. Their focus is to further develop crucial technologies necessary for survival and unimpeded operations in denied CBRN environments. These technologies are transitioned to other Programs of Record as appropriate to enhance the capability of the Joint Force.
JPL CBRND Enabling Biotechnologies enables the rapid development, manufacture, and fielding of safe and effective medical solutions across the full product spectrum, including development, clinical trials, manufacturing, and validated biological threat detection materials. These solutions support programs across the JPEO-CBRND portfolio by lowering product development risks and accelerating product maturity.
JPL CBRN Integration is responsible for the total lifecycle of enterprise information technology systems and provides enterprisewise CBRN threat warning and reporting, hazard prediction, and decision support capabilities for the collection, analysis, and dissemination of CBRN defense information. These capabilities provide commanders with more complete situational understanding of all the threats in the battlespace by integrating CBRN defense systems with traditional defense systems.
The JPEO-CBRND's leadership and workforce structure is essential to its mission and goals as the Joint Force's lead for all investments in CBRN defense equipment. Learn how the organization integrates across the headquarters and six Joint Project Management/Lead offices.
As a component of the Chemical and Biological Defense Program, JPEO-CBRND supports the entire joint force by developing solutions that enable our warfighters to fight and win in a chemical, biological, radiological, or nuclear (CBRN) environment. The JPEO-CBRND leads, manages, and directs the acquisition and fielding of CBRN sensors, protective equipment, medical countermeasures, information management systems, defense enabling biotechnologies, and specialized equipment for U.S. Special Forces.
This Command Brief gives an overview of services and support provided to the joint force.
The JPEO-CBRND's Capabilities Catalog provides an in-depth overview of who we are as an organization, our role within the Chemical and Biological Defense Program, leading and managing the acquisition, fielding and integration of CBRN sensors, protective equipment, medical countermeasures and capabilities for Special Operations Force and combined, Joint All Domain Operations. The catalog shares the current and enduring defense products fielded to the joint force.
The JPEO-CBRND Digital Transformation SmartBook provides an entry-level overview of how our organization is using digital technology for day-to-day operations across our functional areas. Digital Transformation is the adoption of digital technologies to enhance business processes and improve capability development.
Description: Joint Service General Purpose Mask allows Warfighters to survive and maintain ground operations in a chemical and biological threat environment.
Description: The NGDS-1 will identify biological hazards in human clinical specimens and provide diagnostic information to facilitate delivery of appropriate MCMs.
Description: The NBCRV - SSU is a specialized vehicle equipped with a system to detect chemical, radiological, and biological contamination in its immediate environment and automatically warn soldiers of the risk. The integrated sensor suite combines information from multiple detectors and transmits digital warning messages through the vehicle’s command and control equipment to warn follow-on forces.
Description: The Screening Obscuration Module (SOM) is a modular medium-area and duration screening obscuration capability that is located at the small element level of conventional force units and is employed at the tactical in a mounted or dismounted configuration.
Description: Joint Biological Tactical Detection System’s ability to detect, collect, and identify biological warfare agents at very low concentrations gives Warfighters additional time to make decisions and take action to prevent or reduce the risk of exposure.
Description: The DOD-ADM allows the DOD to quickly develop and manufacture medical countermeasures to protect and treat U.S. forces in the event of a CBRN event or an infectious disease outbreak. The ADM is a contractor-owned, contractor-operated facility that fills a critical infrastructure gap in the nation's medical countermeasures manufacturing capacity. The DOD-ADM is a state-of-the-art biopharmaceutical manufacturing facility that utilizes both single-use and stainless steel manufacturing technologies. The facility is 183,000 square feet and is complaint with both the Food and Drug Administration's current Good Manufacturing Practices and the Center for Disease Control and Prevention's Biological Safety Level 3 requirements.
Description: JHBI provides the capability to rapidly and accurately identify bio-agents at the point of contact in a handheld Polymerase Chain Reaction (PCR) device that includes integrated/automated sample preparation (ISP).